| Symbol | PUMD |
|---|---|
| Name | PROUROCARE MEDICAL, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 55344 United States MN 6440 Flying Cloud Drive Suite 101 |
| Telephone | (952) 476-9093 |
| Fax | — |
| — | |
| Website | http://www.prourocare.com/index.html |
| Incorporation | US |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Baker Tilly US, LLP; |
| Audit Status | NOT AVAILABLE |
| Reporting Status | Dark: Alternative Reporting Standard |
| CIK | 0001222244 |
| Description | ProUroCare is engaged in the business of developing innovative products for the detection and characterization of male prostate disease. The companys initial product, a "prostate mechanical imaging" device called the ProUroScan system, was approved by the FDA for commercialization in the United States in April 2012. Additional info from OTC: |
Expert Market symbol attribute type Security_Name was changed. Previous value: -. New value: PROUROCARE MED INC.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: PROUROCARE MED INC.
Read more